By Mark Spinner – The move toward an omnichannel communications strategy in revenue cycle—from secure texts to online chat, patient portals and phone support—creates a customized experience that boosts patient satisfaction and financial engagement.
Read More
By Matt Fisher – The Office for Civil Rights announced its twentieth HIPAA right of access settlement on September 10, 2021, which continues the initiative that has been a primary focal point of enforcement for the past couple of years.
New On Demand Dr. Nick: The Incrementalist: With guest Jay Sultan, Vice President of Strategy, Healthcare, LexisNexis Risk Solutions, who arrived into healthcare as a technologist.
By Art Gross – Bigger business, bigger problems, right? Not necessarily true when it comes to the cost of a cyberattack within the healthcare industry. A recently published survey brings unexpected results when it comes to comparing large and medium-sized businesses.
By David W. Johnson – In the classic “Casablanca,” cynical restaurateur Rick Blaine operates Rick’s Café Américain in occupied French Morocco during WWII. In an iconic scene, Louis tells Rick that he’s closing his establishment because he’s “shocked, shocked to learn there’s gambling in the cafe” just as a casino worker hands Louis his winnings.
By Robert Godard – Data security is a hot topic across industries, and considering the growing threats to data, the need to protect sensitive data is increasingly important. However, the discipline of data security is fragmented in terms of the systems used to enhance protection.
By Devin Partida – The Health Insurance Portability and Accountability Act (HIPAA) is a popular topic of conversation today. While these regulations and how they pertain to hospital security practices have always been relevant, they’ve attained unprecedented press recently.
By Dr. Lee A. Fleisher – CMS is committed to ensuring people on Medicare have quicker access to innovative medical technologies for life-threatening or irreversibly debilitating diseases – like cancer and heart disease. In January 2021, we published a final rule called The Medicare Coverage of Innovative Technology and Definition of ‘Reasonable and Necessary’ (MCIT/R&N).
By John Pizzonia – Post-pandemic, medical device companies need to reimagine approaches to accelerating Innovation. After spending more than 20 years of my career in R&D with leading medical device and life sciences companies, it’s no secret to me that speed matters when it comes to product development and go-to-market.